Abstract
Simultaneous liver–kidney transplant (SLKT) has become a well-established therapeutic option for end-stage renal and liver disease. There is compelling evidence supporting the theory for an immunoprotective role assumed by the transplanted liver in preventing renal allograft rejection in SLKT from the same donor. Prioritization of liver transplant candidates with renal dysfunction by the MELD system has resulted in a substantial increase in the number of SLK transplants. The increasing prevalence of acute and chronic renal dysfunction among liver transplant candidates coupled with the burgeoning kidney transplant waitlist has motivated physicians to define and standardize selection criteria for SLKT. These include the definition and duration of acute kidney injuries (AKI), glomerular filtration rate (GFR) determination, and the duration of dialysis. The ideal cadaveric heart-beating donor for SLKT is aged < 60 years without history of kidney diseases, hypertension, and/or diabetes in stable pressure condition without or with mild dosage of vasopressor drugs. More often, cadaveric heart-beating donors are extended criteria donors (ECD), and liver biopsy is mandatory to assess the liver quality especially in the case of hepatitis B virus antibody core antigen positive, moderate or severe liver steatosis, and age > 60 years; in the latter case, a kidney biopsy is also mandatory to evaluate whether the kidneys are suitable for single kidney transplant or double kidney transplant or not suitable for transplant.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Jain A, Reyes J, Kashyap R, et al. Long-term survival after liver transplantation in 4000 consecutive patients at a single center. Ann Surg. 2000;232(4):490–500.
US Multicenter FK-506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med. 1994;331(17):1110–5.
Gonwa TA, Mai ML, Melton LB, et al. End-Stage Renal Disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy. Transplantation. 2001;72(12):1934–9.
Fisher NC, Nightingale PG, Gunson BK, et al. Chronic renal failure after liver transplantation: a retrospective analysis. Transplantation. 1998;66(1):59–66.
Klintmalm GB, Gonwa TA. Nephrotoxicity associated with cyclosporine and FK506. Liver Transpl Surg. 1995;1(5 Suppl 1):11–9.
Jindal RM, Popescu I. Renal dysfunction associated with liver transplantation. Postgrad Med. 1995;71:513–24.
Davis CL, Gonwa TA, Wilkinson AH. Identification of patients best suited for combined liver kidney transplantation: part II. Liver Transpl. 2002;8(3):193–211.
Chava SP, Singh B, Zaman MB, et al. Current indications for combined liver and kidney transplantation in adults. Transplant Rev (Orlando). 2009;23(2):111–9.
Margreiter R, Kramer R, Huber C, et al. Combined liver and kidney transplantation. Lancet. 1984;1(8385):1077–8.
Davis CL, Feng S, Sung R, et al. Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant. 2007;7:1702–9.
Eason JD, Gonwa TA, Davis CL, et al. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). Am J Transplant. 2008;8:2243–51.
Nadim MK, Sung RS, Davis CL, et al. Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant. 2012;12:2901–8.
Brown Jr RS, Lake JR. The survival impact of liver transplantation in the MELD era, and the future for organ allocation and distribution. Am J Transplant. 2005;5:203–4.
Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology. 2007;45:797–805.
Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transplant. 2006;6:2651–9.
Narayanan Menon KV, Nyberg SL, Harmsen WS, et al. MELD and other factors associated with survival after liver transplantation. Am J Transplant. 2004;4:819–25.
Bahirwani R, Campbell MS, Siropaides T, et al. Transplantation: impact of pretransplant renal insufficiency. Liver Transpl. 2008;14:665–71.
Northup PG, Argo CK, Bakhru MR, Schmitt TM, Berg CL, Rosner MH. Pretransplant predictors of recovery of renal function after liver transplantation. Liver Transpl. 2010;16:440–6.
Cabezuelo JB, Ramirez P, Rios A, et al. Risk factors of acute renal failure after liver transplantation. Kidney Int. 2006;69:1073–80.
Zand MS, Orloff MS, Abt P, et al. High mortality in orthotopic liver transplant recipients who require hemodialysis. Clin Transplant. 2011;25:213–21.
Cassuto JR, Reese PP, Sonnad S, et al. Wait list death and survival benefit of kidney transplantation among nonrenal transplant recipients. Am J Transplant. 2010;10:2502–11.
Srinivas TR, Stephany BR, Budev M, et al. An emerging population: kidney transplant candidates who are placed on the waiting list after liver, heart, and lung transplantation. Clin J Am Soc Nephrol. 2010;5:1881–6.
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care. 2004;8:R204–12.
Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.
Jenq CC, Tsai MH, Tian YC, et al. RIFLE classification can predict short-term prognosis in critically ill cirrhotic patients. Intensive Care Med. 2007;33:1921–30.
Cholongitas E, Calvaruso V, Senzolo M, et al. RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit. J Gastroenterol Hepatol. 2009;24:1639–47.
du Cheyron D, Bouchet B, Parienti JJ, Ramakers M, Charbonneau P. The attributable mortality of acute renal failure in critically ill patients with liver cirrhosis. Intensive Care Med. 2005;31:1693–9.
O’Riordan A, Wong V, McQuillan R, McCormick PA, Hegarty JE, Watson AJ. Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation. Am J Transplant. 2007;7:168–76.
Ferreira AC, Nolasco F, Carvalho D, et al. Impact of RIFLE classification in liver transplantation. Clin Transplant. 2010;24:394–400.
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39 Suppl 1:S1–266.
Wood RP, Ellis D, Starzel TE. The reversal of the hepatorenal syndrome in four pediatric patients following successful orthotopic liver transplantation. Ann Surg. 1987;205(4):415–9.
Iwatsuki S, Popovtzer MM, Goldstein G, et al. Recovery from “hepatorenal syndrome” after orthotopic liver transplantation. N Engl J Med. 1973;289(22):1155–9.
Koppel MH, Coburn JW, Mims MM, et al. Transplantation of cadaveric kidneys from patients with hepatorenal syndrome: evidence for the functional nature of renal failure in advanced liver disease. N Engl J Med. 1969;280(25):1367–71.
McGuire BM, Julian BA, Bynon S, et al. Brief communication: glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation. Ann Intern Med. 2006;144(10):735–41.
Morales JM, Pascual-Capdevila J, Campistol JM, et al. Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. Transplantation. 1997;63(11):1634–9.
Cosio FG, Roche Z, Agarwal A, et al. Prevalence of hepatitis C in patients with idiopathic glomerulopathies in native and transplant kidneys. Am J Kidney Dis. 1996;28(5):752–8.
Kim JY, Akalin E, Dikman S, et al. The variable pathology of kidney disease after liver transplantation. Transplantation. 2010;89(2):215–21.
Campbell MS, Constantinescu S, Furth EE, Reddy KR, Bloom RD. Effects of hepatitis C-induced liver fibrosis on survival in kidney transplant candidates. Dig Dis Sci. 2007;52:2501–7.
Cooper M. Renal transplantation in ESRD with cirrhosis. Presentation at ASTS/AST/UNOS/ASN consensus conference on simultaneous liver-kidney transplantation; Sept 10–11, 2007 Chicago.
Ripoll C, Groszmann R, Garcia-Tsao G, Portal Hypertension Collaborative Group, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133:481–8.
Davis CL. Impact of pretransplant renal failure: when is listing for kidney-liver indicated? Liver Transpl. 2005;11(11 Suppl 2):S35.
Ruiz R, Kunitake H, Wilkinson AH, et al. Long-term analysis of combined liver and kidney transplantation at a single center. Arch Surg. 2006;141:735; discussion 741–2.
Dube GK, Cohen DJ. Simultaneous liver and kidney transplantation. Curr Opin Nephrol Hypertens. 2007;16:547.
Starlz TE, Hakala TR, Shaw BW, et al. A flexible procedure for multiple cadaveric organ harvesting. Surg Gynecol Obstet. 1987;165:343–8.
Casavilla A, Gordon RD, Starlz TE. Techniques of liver transplantation. In: Blumgart LH, editor. Surgery of the liver and biliary tract. New York: Churchill Livingstone; 1994. p. 1870–88.
Shaw Jr BW, Martin DJ, Marquez JM, et al. Venous bypass in clinical liver transplantation. Ann Surg. 1984;200:524–34.
Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg. 1989;210:649–52.
Starzl TE, Iwatsuki S. A growth factor in fine vascular anastomoses. Surg Gynecol Obstet. 1984;159:164–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Del Gaudio, M. et al. (2015). Combined Abdominal Transplantation: Liver–Kidney. In: Pinna, A., Ercolani, G. (eds) Abdominal Solid Organ Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-16997-2_30
Download citation
DOI: https://doi.org/10.1007/978-3-319-16997-2_30
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-16996-5
Online ISBN: 978-3-319-16997-2
eBook Packages: MedicineMedicine (R0)